ClassID:

93418

C07C311/04 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms

Recent Application in this class:
#1
20250100986
2025-03-27

BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS

#2
20240254077
2024-08-01

METHODS OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCLUDING COMPOUNDS USEFUL THEREIN

#3
20240253023
2024-08-01

PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS

#4
20240245691
2024-07-25

2-METHYLENE-4-OXO-BUTANOIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATION

#5
20230234944
2023-07-27

NOVEL COMPOUND USEFUL AS TOLL-LIKE RECEPTOR 7 ACTIVATION INHIBITOR

#6
20220213016
2022-07-07

Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same

#7
20210387957
2021-12-16

Bisphenol derivatives and their use as androgen receptor activity modulators

#8
20200317628
2020-10-08

Bisphenol derivatives and their use as androgen receptor activity modulators

#9
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#10
20200017488
2020-01-16

Heterocyclic inhibitors of the sodium channel

#11
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#12
20190023709
2019-01-24

SHIP1 MODULATORS AND METHODS RELATED THERETO

#13
20180334417
2018-11-22

Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same

#14
20180334416
2018-11-22

Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same

#15
20170253596
2017-09-07

SHIP1 MODULATORS AND METHODS RELATED THERETO

#16
20170129851
2017-05-11

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#17
20170022153
2017-01-26

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

#18
20160282717
2016-09-29

Resist composition, method for forming resist pattern, photo-reactive quencher and compound

#19
20160280679
2016-09-29

Resist composition, method of forming resist pattern, acid generator, photoreactive quencher, and compound

#20
20160083387
2016-03-24

SHIP1 modulators and methods related thereto

#21
20150250792
2015-09-10

Alpha hydroxy amides

#22
20150239829
2015-08-27

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#23
20140288077
2014-09-25

SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY

#24
20140256701
2014-09-11

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#25
20130261133
2013-10-03

Therapeutic Compounds for Protozoal and Microbial Infections and Cancer

#26
20130184279
2013-07-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#27
20130109701
2013-05-02

Acyl sulfonamide compounds

#28
20120322761
2012-12-20

Heterocyclic CETP inhibitors

#29
20120302534
2012-11-29

DERIVATIVES OF BETULIN

#30
20120270901
2012-10-25

Indene derivatives as pharmaceutical agents

#31
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

#32
20120201962
2012-08-09

Composition, compound and film forming method

#33
20120077796
2012-03-29

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#34
20120035196
2012-02-09

CARBOXYLIC ACID COMPOUND

#35
20110207937
2011-08-25

Compounds that inhibit (block) bitter taste in composition and methods of making same

#36
20110172258
2011-07-14

INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS

#37
20110021448
2011-01-27

Inhibitors for the soluble epoxide hydrolase

#38
20110009439
2011-01-13

Indene derivatives as pharmaceutical agents

#39
20100267669
2010-10-21

Heterocyclic CETP inhibitors

#40
20100256209
2010-10-07

COMPOSITIONS COMPRISING ETHER COMPOUNDS AND PHARMACEUTICAL USES THEREFOR

#41
20100249024
2010-09-30

CETP inhibitors

#42
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#43
20100168108
2010-07-01

PHENYL DERIVATIVES AND METHODS OF USE

#44
20100158996
2010-06-24

ESTER COMPOUND AND MEDICAL USE THEREOF

#45
20100152220
2010-06-17

Indene derivatives as pharmaceutical agents

#46
20100105905
2010-04-29

EP2 Agonists

#47
20100041892
2010-02-18

Therapeutic agent for diabetes

#48
20100041717
2010-02-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#49
20090326039
2009-12-31

Inhibitors for the soluble epoxide hydrolase

#50
20090298898
2009-12-03

PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES

#51
20090274632
2009-11-05

Compounds that inhibit (block) bitter taste in composition and use thereof

#52
20090270631
2009-10-29

Therapeutic agent for diabetes

#53
20090246141
2009-10-01

Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure

#54
20090203663
2009-08-13

CHEMICAL COMPOUNDS

#55
20090029903
2009-01-29

1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors

#56
20080200525
2008-08-21

Pesticidally active ketone and oxime derivatives

#57
20080167347
2008-07-10

Ctgf Expression Inhibitor

#58
20080045545
2008-02-21

EP2 agonists

#59
20080009530
2008-01-10

Therapeutic Agent for Diabetes

#60
20080004301
2008-01-03

Benzene compound having 2 or more substituents

#61
20070225365
2007-09-27

CETP inhibitors

#62
20070135631
2007-06-14

Heterocyclic CETP inhibitors

#63
20070129354
2007-06-07

Biphenyl carboxylic amide p38 kinase inhibitors

#64
20070105859
2007-05-10

4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors

#65
20070082907
2007-04-12

Peroxisome proliferator activated receptor modulators

#66
20060270609
2006-11-30

Inhibitors for the soluble epoxide hydrolase

#67
20060128670
2006-06-15

Pesticidally active ketone and oxime derivatives

#68
20060116410
2006-06-01

4-Aminomethyl benzamidine derivatives

#69
20060074086
2006-04-06

Phenyl derivatives and methods of use

#70
20060030599
2006-02-09

Sulphonamide derivatives

#71
20050164951
2005-07-28

Inhibitors for the soluble epoxide hydrolase

#72
20050153958
2005-07-14

Substituted aryl ketones

#73
20050123831
2005-06-09

Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials

#74
20050119333
2005-06-02

Compositions comprising ether compounds and pharmaceutical uses therefor

#75
20050075367
2005-04-07

Ester compound and medicinal use thereof

#76
20050074668
2005-04-07

Perfluorinated amide salts and their uses as ionic conducting materials

#77
20050054883
2005-03-10

Compound, fluorine-containing polymerizable cyclic olefin compound

#78
20050026844
2005-02-03

Inhibitors for the soluble epoxide hydrolase

#79
20050004086
2005-01-06

Indene derivatives as pharmaceutical agents

#80
20050004082
2005-01-06

Ether compounds